NDC product
Vecamyl
NDC 69413-558 · Vyera Pharmaceuticals, LLC
Key facts
| Product NDC | 69413-558 |
|---|---|
| Proprietary name | Vecamyl |
| Nonproprietary name | Mecamylamine Hydrochloride |
| Substances | MECAMYLAMINE HYDROCHLORIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Vyera Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA204054 |
| Pharmacologic classes | Autonomic Ganglionic Blocker [EPC], Decreased Autonomic Ganglionic Activity [PE] |
| Marketing start | Mar 19, 2013 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: